FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1266611000001100: Co-codamol 30mg/500mg tablets 500 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21449101000001110 Co-codamol 30mg/500mg tablets 500 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21449201000001115 Co-codamol 30mg/500mg tablets 500 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-codamol 30mg/500mg tablets 500 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Is pack of Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has active ingredient Codeine phosphate false Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has VMP Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has specific active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-codamol 30mg/500mg tablets 500 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kapake 30mg/500mg tablets (Galen Ltd) 500 tablet Is a True Co-codamol 30mg/500mg tablets 500 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start